Affiliation:
1. Department of Family Medicine, Konya Health Application and Research Center, University of Health Sciences
2. Department Of Child And Adolescent Psychiatry, Konya Health Application and Research Center, University of Health Sciences
3. Department of Biochemistry, Selcuk University, Medical Faculty
4. Department of Nephrology, University of Health Sciences, Training and Research Hospital
5. Department of General Surgery, Konya Health Application and Research Center, University of Health Sciences
Abstract
Aim: In this study, we aimed to determine changes in leukocytes volume, conductivity and scatter parameters in smokers compared to non-smokers.
Methods: A total of 117 individuals (45 smokers and 72 non-smokers) were included in the study. While those who smoked at least 10 pack-years were included in the case group, those who never smoked at all were included in the control group.
Results: While there was a statistically significant difference in mean neutrophil volume, mean neutrophil conductivity, mean lymphocyte conductivity, mean lymphocyte scatter, mean monocyte volume, mean monocyte conductivity, mean monocyte scatter, mean eosinophil conductivity values between the two groups, there was no statistically significant difference in mean neutrophil scatter, mean lymphocyte volume, mean eosinophil volume, mean eosinophil scatter values between the two groups.
Conclusion: This study showed that smoking affected volume, conductivity and scatter parameters. Clinicians should consider whether the patient smokes if they want to diagnose any diseases using volume, conductivity and scatter parameters.
Keywords: smoking, leukocytes, conductivity, scattering, neutrophils
Publisher
Eurasian Society of Family Medicine
Reference22 articles.
1. Office of the Surgeon General (US); Office on Smoking and Health (US). The health consequences of smoking: a report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention; 2004. PMID: 20669512
2. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. Circulation. 1997;96(9):3243-7.
3. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991;22(3):312-8.
4. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007;131(5):1557-66.
5. Levitzky YS, Guo C-Y, Rong J, Larson MG, Walter RE, Keaney Jr JF, et al. Relation of smoking status to a panel of inflammatory markers: the Framingham offspring. Atherosclerosis 2008;201(1):217-24.